Calmark Sweden AB develops and commercialises systems for the rapid detection of cell injury markers in micro-volume samples. The systems are designed for ”point-of-care” use in emergency- and intensive care. Calmark’s technology has the potential to detect cell damage in a variety of applications where volume, time and place are critical – but often limited – factors.


HQ: Karlstad, Sweden

MD: Mathias Karlsson